Developer docs
API playgroundTry for free, no card

Search company profiles

Opvia

Full company profile

uuid0006q4v

Namestring
Opvia
Websiteurl
opvia.io
Company typeenum
Private
Founded yearint
2019
Descriptiontext

Opvia Limited, operating commercially as Seal, is a London-based software company that builds an AI-native execution platform for GxP-regulated life sciences organizations. The platform ingests unstructured standard operating procedures (SOPs) — in PDF, Word, or paper-scan form — and converts them into controlled, executable digital workflows with review gates, e-signatures, operator training assignments, audit trails, and validation evidence. Its central AI agent, neil, is state-aware and proposes workflow builds from document clauses, surfaces deviations, compares run histories, and scopes process changes while the underlying system remains live. The product is delivered as a cloud-based SaaS suite comprising six blueprints — Manufacturing Execution System (MES), Quality Management System (QMS), QC LIMS, Tech Transfer, Electronic Lab Notebook (ELN), and Inventory Management — that share a common controlled execution spine.

Seal's technology is differentiated by the 48-hour build process, under which a single customer SOP is turned into a live, validated, controlled workflow with auto-generated validation evidence in two days — a step-change versus the multi-month revalidation cycles typical of legacy GxP stacks. The platform is designed for environments governed by FDA/EMA regulations and incorporates 21 CFR Part 11 compliance concepts, continuous audit trails, and change-control workflows that do not require taking processes offline.

Seal generates revenue through subscription SaaS contracts sold via a high-touch, consultative enterprise sales motion. Pricing is not publicly disclosed; prospects engage through "Talk to an Expert" and "Send us one SOP" calls-to-action, with the 48-hour build functioning simultaneously as a proof of concept and an onboarding mechanism. The company's target market is pharmaceutical, biotech, biologics, diagnostics, and adjacent GxP-adjacent companies — over 50 of which are referenced as customers, including Paradromics, Skye Biologics, Acclinate, Bioventix, MiAlgae, Agilent, Beckman Coulter, Ingenza, and Latitude Pharmaceuticals. Seal is venture-backed, having raised a seed round from Y Combinator and Cur8 Capital in 2020 and a follow-on round led by Liquid 2 Ventures in 2022, and is led by founder and CEO William Moss.

Short descriptiontext

Opvia, operating as Seal, is a London-based SaaS company that provides an AI-native GxP execution platform converting SOPs into controlled, validated workflows for pharmaceutical, biotech, and life sciences companies. Its AI agent neil and 48-hour onboarding differentiate it from legacy MES/QMS vendors.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
GxP compliance software, pharmaceutical manufacturing software, quality management system, electronic batch records, lab execution platform
Industry2 codes
PRIMARYHLAGAKAG
Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPAAAKAB
OCR, ICR & Intelligent Document Processing (IDP)
NAICS code1 code
  • Software Publishers513210
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Processing & Data Preparation7374
Product category
GxP Compliance Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1SaaS Platform Subscription
TypeSubscription Recurring
Description

Seal operates as a cloud-based SaaS platform for GxP-regulated companies, likely on a subscription basis. Pricing is not publicly disclosed and requires inquiry. The platform encompasses MES, QMS, LIMS, Tech Transfer, ELN, and Inventory modules under a unified controlled execution system.

seal.run
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Opvia operates "Seal," an AI-native GxP execution platform that converts SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. The platform serves GxP-regulated pharmaceutical, biotech, biologics, and life sciences companies with modular blueprints for manufacturing execution, quality management, QC LIMS, tech transfer, electronic lab notebooks, and inventory management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 90% less time on traveler review
+5 more records
Product overview1 text field

Seal is an AI-native GxP execution platform that transforms static SOPs into controlled, executable workflows. The core platform uses an AI agent called neil to parse documents and generate workflows with compliance features. The platform offers a modular architecture with specialized blueprints including MES (Manufacturing Execution System), QMS (Quality Management System), QC LIMS, Tech Transfer, ELN (Electronic Lab Notebook), and Inventory Management modules. All modules share a common execution spine with integrated training, approvals, audit trails, and validation evidence.

Product and service2 records
1Seal
CategoryGxP Compliance Software / Pharmaceutical Manufacturing Execution
Description

AI-native GxP execution platform that transforms SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. First process goes live within 48 hours. Built for GxP-regulated life sciences companies including pharmaceutical, biotech, biologics, and medical device organizations. Modular blueprints cover MES, QMS, QC LIMS, Tech Transfer, ELN, and Inventory Management.

2neil
CategoryAI Execution Agent
Description

State-aware AI execution agent within the Seal platform that reads SOPs (PDF, Word, or paper scans), proposes workflow builds, scopes changes, identifies missing checks, compares run history, simulates next changes, and routes approvals through the controlled system.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Dominant life sciences cloud platform with Veeva Vault covering quality, regulatory, and clinical documents. Directly competes with Seal in the GxP/QMS layer but serves a much broader portfolio across pharma.

TypeDirect peer
Description

Long-standing GxP quality and manufacturing execution platform used by pharma/biotech/medical device companies. Directly competes with Seal's QMS and MES modules for the same regulated customer base.

TypeDirect peer
Description

AI-enabled QMS and quality management for life sciences on Salesforce. Competes with Seal in digitizing SOPs and quality workflows under GxP, with a similar focus on modern UX and faster deployment.

TypeDirect peer
Description

Electronic validation and process execution software purpose-built for GxP-regulated life sciences. Directly comparable to Seal's validation evidence generation and controlled workflow capabilities.

TypeDirect peer
Description

Cloud QMS designed for life sciences startups and mid-market pharma/biotech. Competes with Seal's QMS blueprint for the same early-to-mid-stage GxP customer segment.

TypeBroad incumbent
Description

Established LIMS and laboratory informatics vendor used across pharma, biotech, and applied markets. Directly competes with Seal's QC LIMS blueprint and shares GxP validation requirements.

TypeEmerging player
Description

QMS platform purpose-built for medical device companies under FDA/ISO 13485. Comparable to Seal in modern UX and vertical specialization, but narrower scope (medical devices only).

TypeEmerging player
Description

Cloud QMS with life sciences and manufacturing modules. Competes for the same mid-market GxP customer base as Seal, though with a more traditional QMS-only positioning.

TypeEmerging player
Description

Cloud QMS designed for pharma, biotech, and medical device companies under GxP and 21 CFR Part 11. Directly comparable to Seal's QMS module with a similar compliance-led value proposition.

TypeEmerging player
Description

Frontline operations and manufacturing execution platform increasingly adopted in life sciences. Comparable to Seal's MES blueprint and shared emphasis on connected operator workflows and real-time data capture.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Opvia

GxP Compliance Softwareopvia.io

Opvia, operating as Seal, is a London-based SaaS company that provides an AI-native GxP execution platform converting SOPs into controlled, validated workflows for pharmaceutical, biotech, and life sciences companies. Its AI agent neil and 48-hour onboarding differentiate it from legacy MES/QMS vendors.

What Opvia does

Opvia Limited, operating commercially as Seal, is a London-based software company that builds an AI-native execution platform for GxP-regulated life sciences organizations. The platform ingests unstructured standard operating procedures (SOPs) — in PDF, Word, or paper-scan form — and converts them into controlled, executable digital workflows with review gates, e-signatures, operator training assignments, audit trails, and validation evidence. Its central AI agent, neil, is state-aware and proposes workflow builds from document clauses, surfaces deviations, compares run histories, and scopes process changes while the underlying system remains live. The product is delivered as a cloud-based SaaS suite comprising six blueprints — Manufacturing Execution System (MES), Quality Management System (QMS), QC LIMS, Tech Transfer, Electronic Lab Notebook (ELN), and Inventory Management — that share a common controlled execution spine.

Seal's technology is differentiated by the 48-hour build process, under which a single customer SOP is turned into a live, validated, controlled workflow with auto-generated validation evidence in two days — a step-change versus the multi-month revalidation cycles typical of legacy GxP stacks. The platform is designed for environments governed by FDA/EMA regulations and incorporates 21 CFR Part 11 compliance concepts, continuous audit trails, and change-control workflows that do not require taking processes offline.

Seal generates revenue through subscription SaaS contracts sold via a high-touch, consultative enterprise sales motion. Pricing is not publicly disclosed; prospects engage through "Talk to an Expert" and "Send us one SOP" calls-to-action, with the 48-hour build functioning simultaneously as a proof of concept and an onboarding mechanism. The company's target market is pharmaceutical, biotech, biologics, diagnostics, and adjacent GxP-adjacent companies — over 50 of which are referenced as customers, including Paradromics, Skye Biologics, Acclinate, Bioventix, MiAlgae, Agilent, Beckman Coulter, Ingenza, and Latitude Pharmaceuticals. Seal is venture-backed, having raised a seed round from Y Combinator and Cur8 Capital in 2020 and a follow-on round led by Liquid 2 Ventures in 2022, and is led by founder and CEO William Moss.

Opvia firmographics

Firmographics
Name
Opvia
Website
https://opvia.io
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
Opvia, operating as Seal, is a London-based SaaS company that provides an AI-native GxP execution platform converting SOPs into controlled, validated workflows for pharmaceutical, biotech, and life sciences companies. Its AI agent neil and 48-hour onboarding differentiate it from legacy MES/QMS vendors.
Ownership category
akta.pro rank

Opvia industry classification

Industry
Product category
GxP Compliance Software
NAICS
Software Publishers (513210)
SIC
Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374)
akta.pro industry
PRIMARYHLAGAKAG
Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
SECONDARYBPAAAKAB
OCR, ICR & Intelligent Document Processing (IDP)

Keywords

  • GxP compliance software
  • Pharmaceutical manufacturing software
  • Quality management system
  • Electronic batch records
  • Lab execution platform

Where Opvia is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Markets served

Opvia business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. SaaS Platform Subscription: Seal operates as a cloud-based SaaS platform for GxP-regulated companies, likely on a subscription basis. Pricing is not publicly disclosed and requires inquiry. The platform encompasses MES, QMS, LIMS, Tech Transfer, ELN, and Inventory modules under a unified controlled execution system.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Opvia product offering

Product offering

Core offering

Opvia operates "Seal," an AI-native GxP execution platform that converts SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. The platform serves GxP-regulated pharmaceutical, biotech, biologics, and life sciences companies with modular blueprints for manufacturing execution, quality management, QC LIMS, tech transfer, electronic lab notebooks, and inventory management.

Product overview

Seal is an AI-native GxP execution platform that transforms static SOPs into controlled, executable workflows. The core platform uses an AI agent called neil to parse documents and generate workflows with compliance features. The platform offers a modular architecture with specialized blueprints including MES (Manufacturing Execution System), QMS (Quality Management System), QC LIMS, Tech Transfer, ELN (Electronic Lab Notebook), and Inventory Management modules. All modules share a common execution spine with integrated training, approvals, audit trails, and validation evidence.

Differentiator

Problem solved

Functional benefit

Products and services

  • Seal AI-native GxP execution platform that transforms SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. First process goes live within 48 hours. Built for GxP-regulated life sciences companies including pharmaceutical, biotech, biologics, and medical device organizations. Modular blueprints cover MES, QMS, QC LIMS, Tech Transfer, ELN, and Inventory Management.
  • neil State-aware AI execution agent within the Seal platform that reads SOPs (PDF, Word, or paper scans), proposes workflow builds, scopes changes, identifies missing checks, compares run history, simulates next changes, and routes approvals through the controlled system.

Quantifiable outcome

  • 90% less time on traveler review
  • +5 more outcomes

Companies that use Opvia

Customer profile

Named customers9 records

Segments1 record

Ideal customer profiles1 record

Opvia technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Opvia partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Opvia competitors and assessment

Company assessment

Broad incumbents

  • Veeva Systems: Dominant life sciences cloud platform with Veeva Vault covering quality, regulatory, and clinical documents. Directly competes with Seal in the GxP/QMS layer but serves a much broader portfolio across pharma.
  • LabWare: Established LIMS and laboratory informatics vendor used across pharma, biotech, and applied markets. Directly competes with Seal's QC LIMS blueprint and shares GxP validation requirements.

Direct peers

  • MasterControl: Long-standing GxP quality and manufacturing execution platform used by pharma/biotech/medical device companies. Directly competes with Seal's QMS and MES modules for the same regulated customer base.
  • Dot Compliance: AI-enabled QMS and quality management for life sciences on Salesforce. Competes with Seal in digitizing SOPs and quality workflows under GxP, with a similar focus on modern UX and faster deployment.
  • Kneat (Smart Pharma): Electronic validation and process execution software purpose-built for GxP-regulated life sciences. Directly comparable to Seal's validation evidence generation and controlled workflow capabilities.
  • Qualio: Cloud QMS designed for life sciences startups and mid-market pharma/biotech. Competes with Seal's QMS blueprint for the same early-to-mid-stage GxP customer segment.

Emerging players

  • Greenlight Guru: QMS platform purpose-built for medical device companies under FDA/ISO 13485. Comparable to Seal in modern UX and vertical specialization, but narrower scope (medical devices only).
  • QT9 Software: Cloud QMS with life sciences and manufacturing modules. Competes for the same mid-market GxP customer base as Seal, though with a more traditional QMS-only positioning.
  • SimplerQMS: Cloud QMS designed for pharma, biotech, and medical device companies under GxP and 21 CFR Part 11. Directly comparable to Seal's QMS module with a similar compliance-led value proposition.
  • Tulip: Frontline operations and manufacturing execution platform increasingly adopted in life sciences. Comparable to Seal's MES blueprint and shared emphasis on connected operator workflows and real-time data capture.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Opvia social profiles

Digital presence

Opvia financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Opvia leadership team

Management profile

Number of profiles

Profiles1 record

Opvia funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Opvia M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Opvia

What does Opvia do?

Opvia operates "Seal," an AI-native GxP execution platform that converts SOPs, batch records, methods, and forms into controlled digital workflows with real-time evidence capture, e-signatures, review gates, training integration, and audit trails. The platform serves GxP-regulated pharmaceutical, biotech, biologics, and life sciences companies with modular blueprints for manufacturing execution, quality management, QC LIMS, tech transfer, electronic lab notebooks, and inventory management.

When was Opvia founded?

Opvia was founded in 2019. It employs 11 to 50 people.

Where is Opvia based?

Opvia is headquartered in London, United Kingdom, in the Europe region.

How does Opvia make money?

One revenue line is on record: saaS Platform Subscription.

Who are Opvia's main competitors?

Broad incumbents on record are Veeva Systems and LabWare. Direct peers are MasterControl, Dot Compliance, Kneat (Smart Pharma) and Qualio. Emerging players are Greenlight Guru, QT9 Software, SimplerQMS and Tulip.

Does Opvia have an API?

No public API is recorded for Opvia.

What industry is Opvia in?

Opvia's product category is GxP Compliance Software. Its primary akta.pro industry code is HLAGAKAG, Computer System Validation (CSV) & GxP IT Compliance (21 CFR Part 11/Annex 11), with a secondary code of BPAAAKAB, OCR, ICR & Intelligent Document Processing (IDP). Its NAICS code is 513210 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales